Literature DB >> 32447344

Olaparib for DNA repair-deficient prostate cancer - one for all, or all for one?

Emmanuel S Antonarakis1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32447344     DOI: 10.1038/s41571-020-0395-x

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN: 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  3 in total

1.  Oncogenic Genomic Alterations, Clinical Phenotypes, and Outcomes in Metastatic Castration-Sensitive Prostate Cancer.

Authors:  Philip W Kantoff; Wassim Abida; Konrad H Stopsack; Subhiksha Nandakumar; Andreas G Wibmer; Samuel Haywood; Emily S Weg; Ethan S Barnett; Chloe J Kim; Emily A Carbone; Samantha E Vasselman; Bastien Nguyen; Melanie A Hullings; Howard I Scher; Michael J Morris; David B Solit; Nikolaus Schultz
Journal:  Clin Cancer Res       Date:  2020-03-27       Impact factor: 12.531

2.  Olaparib for Metastatic Castration-Resistant Prostate Cancer.

Authors:  Johann de Bono; Joaquin Mateo; Karim Fizazi; Fred Saad; Neal Shore; Shahneen Sandhu; Kim N Chi; Oliver Sartor; Neeraj Agarwal; David Olmos; Antoine Thiery-Vuillemin; Przemyslaw Twardowski; Niven Mehra; Carsten Goessl; Jinyu Kang; Joseph Burgents; Wenting Wu; Alexander Kohlmann; Carrie A Adelman; Maha Hussain
Journal:  N Engl J Med       Date:  2020-04-28       Impact factor: 91.245

3.  Prospective Comprehensive Genomic Profiling of Primary and Metastatic Prostate Tumors.

Authors:  Jon H Chung; Ninad Dewal; Ethan Sokol; Paul Mathew; Robert Whitehead; Sherri Z Millis; Garrett M Frampton; Gennady Bratslavsky; Sumanta K Pal; Richard J Lee; Andrea Necchi; Jeffrey P Gregg; Primo Lara; Emmanuel S Antonarakis; Vincent A Miller; Jeffrey S Ross; Siraj M Ali; Neeraj Agarwal
Journal:  JCO Precis Oncol       Date:  2019-05-10
  3 in total
  2 in total

1.  Differential Activity of PARP Inhibitors in BRCA1- Versus BRCA2-Altered Metastatic Castration-Resistant Prostate Cancer.

Authors:  Fadi Taza; Albert E Holler; Wei Fu; Hao Wang; Nabil Adra; Costantine Albany; Ryan Ashkar; Heather H Cheng; Alexandra O Sokolova; Neeraj Agarwal; Adam Kessel; Alan Bryce; Nellie Nafissi; Pedro Barata; A Oliver Sartor; Diogo Bastos; Oren Smaletz; Jacob E Berchuck; Mary-Ellen Taplin; Rahul Aggarwal; Cora N Sternberg; Panagiotis J Vlachostergios; Ajjai S Alva; Christopher Su; Catherine H Marshall; Emmanuel S Antonarakis
Journal:  JCO Precis Oncol       Date:  2021-07-22

2.  Targeting DNA repair defects in prostate cancer.

Authors:  Clemens Thoma
Journal:  Nat Rev Urol       Date:  2020-08       Impact factor: 14.432

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.